Therefore, we speculate that the upregulated expression of QPCT also enhances the modification of the N-terminus of CCl2 and leads to improved activity of CCl2 in CHB patients with cirrhosis and liver cancer, which promotes CHB progression and the development of liver cirrhosis and liver cancer. This evidence concerns the gene QPCT and liver cancer.